AlphaCentric Advisors’s Exact Sciences EXAS Stock Holding History

AlphaCentric Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,901	Closed	-$802K	–	271
2025 Q4	$802K	Buy	+7,901	New	+$634K	0.8%	31
2024 Q4	$662K	Sell	11,790 -18,210	-61%	-$1.13M	0.66%	42
2024 Q3	$2.04M	Hold	30,000	–	–	1.52%	19
2024 Q2	$1.27M	Buy	30,000 +1,000	+3%	+$55K	0.93%	35
2024 Q1	$2M	Buy	+29,000	New	+$1.83M	1.21%	24

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaCentric Advisors's EXAS Position: Q1 2026 in Review

AlphaCentric Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,901 shares — an estimated $802K sold.

AlphaCentric Advisors first reported a position in EXAS in Q1 2024 and held it in 5 quarters. The position peaked at $2.04M in Q3 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

AlphaCentric Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
AlphaCentric Advisors sold 7,901 Exact Sciences shares in Q1 2026, an estimated $802K.
AlphaCentric Advisors first reported a position in Exact Sciences in Q1 2024 and held it in 5 quarters.
AlphaCentric Advisors's Exact Sciences position peaked at $2.04M in Q3 2024.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.